Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

VA Contract Update

10 May 2013 07:00

RNS Number : 3944E
Ideagen PLC
10 May 2013
 



 

Ideagen PLC

("Ideagen" or the "Company")

 

VA Contract Update

 

Ideagen PLC (AIM: IDEA), a leading supplier of Compliance based Information Management solutions, announces that the Company has received notification from the US Department of Veterans Affairs (VA) to 'terminate for convenience' year two of the Prism contract expected to complete during November 2013. The cancellation of this contract has no effect on market expectations for the current financial year.

 

As notified in the announcement of 29 November 2012, approximately 70% of the anticipated revenue from year two of the contract of approximately ÂŁ1.05 million was recognised in the financial period ending 30 April 2013. Given the current nature of the US Federal budgets the Company had made ample contingency within its business plan to ensure that in the event of this programme discontinuing following the second year of the contract there would be no impact on the current market expectations for the financial period ending 30 April 2014. The Company therefore remains confident in meeting market expectations for the financial period ending 30 April 2014.

 

The decision to terminate year two of the Prism contract was made for budgetary reasons and the Company remains a trusted and important supplier to the VA and will continue to support the existing deployment of Proquis Enterprise™ at 40 VA hospitals across the USA and to market its products to VA hospitals at a local and regional level.

 

The notice to 'terminate for convenience' the Company's Prism contract is a no fault termination right held by the US Government over all Federal Contracts and, as the Company has complied fully with all commercial and technical contractual obligations, it is entitled to a settlement under Federal Acquisition Regulation (FAR) 52.2124 (i) in respect of the second year of the contract to November 2013. The VA has requested a proposal for settlement from the Company which will be submitted as soon as possible.

 

David Hornsby, Chief Executive of Ideagen, commented, "Whilst we are disappointed that year two of the Prism contract has been terminated, I am pleased to report our budgetary processes were robust. The business continues to trade strongly and the Company remains confident of delivering further revenue and profit growth in the current financial period."

 

Enquiries:

 

 

Ideagen Plc

 

Tel: 01629 761590

David Hornsby, Chief Executive

 

 

Graeme Spenceley, Finance Director

 

 

 

 

 

finnCap (Nominated Adviser and Broker)

 

Tel: 020 7220 0500

Matt Goode/Charlotte Stranner (Corporate Finance)

 

 

Stephen Norcross (Corporate Broking)

 

 

 

 

 

Walbrook PR Ltd

 

Tel: 020 7933 8780

Helen Westaway

 

Helen.westaway@walbrookpr.com

Paul Cornelius

 

Paul.cornelius@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPSNEFKDEFF
Date   Source Headline
10th Aug 201711:45 amRNSDirector Dealing
28th Jul 20174:19 pmRNSDirector Dealing
18th Jul 20177:00 amRNSFinal Results
12th Jun 20178:45 amRNSHolding(s) in Company
18th May 20173:19 pmRNSExercise of Options and Total Voting Rights
17th May 20177:00 amRNSPre-Close Trading Update
11th May 20172:21 pmRNSHolding(s) in Company
31st Mar 20171:10 pmRNSDirector/PDMR Shareholding
30th Mar 201711:48 amRNSHolding(s) in Company
30th Mar 20177:00 amRNSNew Aviation SaaS contracts worth £1.8m
28th Mar 20179:16 amRNSHolding(s) in Company
27th Mar 20176:05 pmRNSHolding(s) in Company
23rd Mar 201710:49 amRNSDirectors' Dealing & Total Voting Rights
23rd Mar 20177:00 amRNSAcquisition and Placing to raise £10m
1st Mar 201711:47 amRNSExercise of Options and Total Voting Rights
1st Mar 20177:00 amRNSHolding(s) in Company
24th Feb 20172:28 pmRNSExercise of Options and Total Voting Rights
24th Feb 201712:20 pmRNSHolding(s) in Company
21st Feb 20177:00 amRNSExercise of Options and Total Voting Rights
1st Feb 201711:44 amRNSHolding(s) in Company
26th Jan 20178:29 amRNSDividend Timetable
24th Jan 20177:01 amRNSDirectorate Changes
24th Jan 20177:00 amRNSInterim Results
9th Dec 20167:00 amRNSAcquisition of IPI Solutions Ltd
7th Dec 20162:14 pmRNSHolding(s) in Company
28th Nov 20164:55 pmRNSHolding(s) in Company
24th Nov 20167:00 amRNSHolding(s) in Company
16th Nov 201611:37 amRNSHolding(s) in Company
7th Nov 20167:00 amRNSTrading Update
2nd Nov 20167:00 amRNSExercise of Options and Total Voting Rights
28th Oct 20161:26 pmRNSResult of AGM
13th Oct 20167:00 amRNSNew Contract Wins worth £1.2m
11th Oct 20167:00 amRNSExercise of Options and Total Voting Rights
6th Oct 20167:00 amRNSNotice of AGM
6th Sep 20167:00 amRNSAcquisition of Logen Ltd.
1st Sep 20167:00 amRNSExercise of Options and Total Voting Rights
12th Aug 20167:00 amRNSExercise of Options and Total Voting Rights
8th Aug 20167:00 amRNSAcquisition of Covalent Software Ltd
29th Jul 20167:00 amRNSExercise of Options and Total Voting Rights
19th Jul 20163:28 pmRNSDividend Timetable
19th Jul 20167:00 amRNSFinal Results
12th Jul 20167:00 amRNSNotice of Results
5th Jul 20167:00 amRNSHolding(s) in Company
29th Jun 20161:56 pmRNSHolding(s) in Company
18th May 20167:00 amRNSPre-Close Trading Update
5th May 20167:00 amRNSExercise of Options and Total Voting Rights
29th Apr 20167:00 amRNSNew contract wins in life science sector
29th Mar 20167:00 amRNSExercise of Options and Total Voting Rights
18th Mar 20167:00 amRNSRe £4.9m Contract and Trading Update
29th Jan 20168:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.